StonvexLoading…
StonvexStonvexStonvexCore line items from HPK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $215.88M | $863.36M | $646.71M | $457.85M |
Operating Income | $36.02M | $149.98M | $166.43M | $133.82M |
Net Income | $-127.45M | $18.96M | $44.18M | $26.18M |
EPS (Diluted) | $-1.02 | $0.14 | $0.32 | $0.45 |
Total Assets | $3.13B | $3.21B | $3.20B | $3.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $95.83M | $162.07M | $164.91M | $21.85M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 126.36M | 125.33M | 125.59M | 126.13M |